We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Antimicrobial ‘Superfoam’ Could Reduce Infections from Implanted Medical Devices

By HospiMedica International staff writers
Posted on 01 May 2023

Each year, over 500,000 patients suffer from health care-related infections caused by medical implants. More...

Existing medical devices are susceptible to contamination, as proteins, which are the first to adhere to a surface, act like glue, enabling blood or bacteria to attach. Preventing protein adsorption is therefore crucial. Now, a new, versatile foam material could significantly decrease infections related to implanted medical devices. This porous, three-dimensional foam is water-repellent, which means it resists blood, microbes, and proteins. Its versatility, functionality, and relatively low production costs could make it an invaluable asset for future clinicians.

Scientists at University of Georgia (Athens, GA, USA) have developed a coarse foam material with two added components: hydrophobic (water-repellent) electrically conductive graphene nanoplatelets and hydrophobic bactericidal copper microparticles. These additions not only repel water but also create a coarse surface that enhances oil adsorption capacity. Moreover, the copper, a known bacterial toxin, imparts antimicrobial properties to the surface. The material's effectiveness was confirmed through testing, which revealed a 99.9% bacterial reduction using E. coli as the test bacterium when compared to a simple polymer. The researchers will now aim to apply this surface to medical devices and demonstrate its efficacy before progressing to non-human animal trials and eventually human testing.

 


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.